Lumida
/TBPH
⌘K
Theravance Biopharma Inc

Theravance Biopharma Inc

TBPH
$17.01USD-0.06%-0.01 today

MARKET CAP

883.1M

P/E (TTM)

67.0x

FWD P/E

6.6x

DAY RANGE

$17 – $17

52W RANGE

$13
$21

AI Summary

Stalk
Buy NowMedium

TBPH is exhibiting signs of structural repair with a Bullish Pivot Point pattern and price holding above key short-term EMAs. The intermediate trend is supported by mean-reversion dynamics, while the long-term uptrend remains intact. EMAs are flattening and turning higher, and RSI and Options Score show no exhaustion. The momentum-focused strategy favors participation on shallow pullbacks into rising EMA support.

  • Q1 2026 revenue of $17.7M (+15% YoY) driven by YUPELRI partnership
  • ROE at 50% with high earnings yield underscores strong profitability
  • Analysts’ downward revisions highlight weakening earnings outlook
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income